US Stock MarketDetailed Quotes
ENFN Enfusion
- 8.760
- -0.050-0.57%
Close Oct 18 16:00 ET
- 8.760
- 0.0000.00%
Post 16:20 ET
816.53MMarket Cap219.00P/E (TTM)
8.820High8.760Low115.47KVolume8.820Open8.810Pre Close1.01MTurnover0.28%Turnover Ratio125.14P/E (Static)93.21MShares10.45052wk High12.70P/B365.59MFloat Cap7.52052wk Low--Dividend TTM41.73MShs Float23.210Historical High--Div YieldTTM0.68%Amplitude7.370Historical Low8.781Avg Price1Lot Size
Enfusion Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 21.54%7.31M | 65.91%1.53M | 81.08%25.63M | -12.43%6.59M | 54.37%12.11M | 108.24%6.02M | 122.55%924K | 4,551.57%14.16M | 229.40%7.52M | 439.63%7.84M |
| Net income from continuing operations | 155.21%2.55M | -116.21%-761K | 169.77%9.25M | 14.21%900K | 2.42%2.66M | 124.19%998K | 137.48%4.69M | 95.30%-13.26M | 100.27%788K | -21.08%2.6M |
| Operating gains losses | ---- | ---- | --78K | --0 | ---- | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization | 37.99%2.87M | 43.15%2.67M | 57.42%9.99M | 107.99%3.52M | 48.44%2.52M | 28.92%2.08M | 39.40%1.87M | 59.60%6.34M | 28.42%1.69M | 72.14%1.7M |
| Other non cash items | 22.02%2.1M | 17.53%1.82M | 29.70%6.97M | 11.40%1.71M | 55.98%2M | -32.85%1.72M | 25,766.67%1.55M | 2,322.07%5.38M | --1.54M | 1,628.38%1.28M |
| Change In working capital | -200.13%-4.71M | -39.06%-9.06M | 11.77%-9.44M | -243.95%-2.87M | 48.64%1.53M | 69.58%-1.57M | -13.87%-6.52M | 27.45%-10.69M | 84.61%-835K | 115.16%1.03M |
| -Change in receivables | -207.60%-3.16M | -410.02%-2.72M | 59.26%-3.68M | -204.73%-3.14M | 61.88%-390K | 81.99%-1.03M | 116.53%878K | -20.53%-9.03M | 857.32%3M | 71.83%-1.02M |
| -Change in prepaid assets | 49.61%947K | -181.98%-414K | 1.02%-1.75M | 54.45%-1.83M | -213.87%-1.06M | -52.37%633K | 3,984.62%505K | 72.72%-1.77M | -312.86%-4.01M | 123.11%930K |
| -Change in payables and accrued expense | -195.80%-388K | 44.30%-2.69M | -61.74%2M | 135.38%3.37M | 25.34%3.05M | -76.87%405K | -1,103.99%-4.83M | 776.39%5.22M | 135.26%1.43M | 173.90%2.44M |
| -Change in other current assets | -892.22%-713K | 0.72%-1.65M | ---- | ---- | ---- | --90K | ---1.66M | ---- | ---- | ---- |
| -Change in other current liabilities | 16.15%-1.4M | -12.58%-1.59M | -17.43%-6M | -1.44%-1.27M | -25.08%-1.65M | ---1.67M | ---1.42M | ---5.11M | ---1.25M | ---1.32M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 21.54%7.31M | 65.91%1.53M | 81.08%25.63M | -12.43%6.59M | 54.37%12.11M | 108.24%6.02M | 122.55%924K | 4,551.57%14.16M | 229.40%7.52M | 439.63%7.84M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -157.14%-5.71M | -7.76%-2.75M | -21.94%-9.67M | -31.44%-2.3M | -182.75%-2.61M | -6.07%-2.22M | 19.58%-2.55M | 1.04%-7.93M | -6.40%-1.75M | 53.25%-922K |
| Capital expenditure reported | -19.96%-1.7M | -99.15%-2.11M | -32.24%-5.22M | ---- | ---- | ---1.42M | ---1.06M | -105.74%-3.95M | ---- | ---- |
| Net PPE purchase and sale | -25.47%-1.01M | 57.35%-635K | -11.74%-4.45M | 32.86%2.92M | -451.63%-5.09M | 61.71%-801K | 53.04%-1.49M | 34.63%-3.99M | 694.22%2.2M | 53.25%-922K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -157.14%-5.71M | -7.76%-2.75M | -21.94%-9.67M | -31.44%-2.3M | -182.75%-2.61M | -6.07%-2.22M | 19.58%-2.55M | 1.04%-7.93M | -6.40%-1.75M | 53.25%-922K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 99.95%-16K | 78.39%-1.37M | -441.31%-43.08M | 91.78%-579K | -26,445.00%-5.31M | -33,423.91%-30.84M | -689.19%-6.35M | -113.52%-7.96M | -111.11%-7.04M | 98.88%-20K |
| Net issuance payments of debt | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Net common stock issuance | ---- | ---- | --17.32M | --0 | --7.63M | ---- | ---- | --0 | --0 | --0 |
| Cash dividends paid | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Net other financing activities | 99.96%-16K | 78.39%-1.37M | -658.95%-60.41M | 91.78%-579K | -64,595.00%-12.94M | -43,958.70%-40.53M | -689.19%-6.35M | 24.68%-7.96M | ---7.04M | ---20K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 99.95%-16K | 78.39%-1.37M | -441.31%-43.08M | 91.78%-579K | -26,445.00%-5.31M | -33,423.91%-30.84M | -689.19%-6.35M | -113.52%-7.96M | -111.11%-7.04M | 98.88%-20K |
| Net cash flow | ||||||||||
| Beginning cash position | -39.75%32.89M | -43.07%35.6M | -2.83%62.55M | -50.19%31.65M | -50.90%27.77M | -2.86%54.6M | -2.83%62.55M | 361.80%64.37M | 653.59%63.54M | 289.66%56.56M |
| Current changes in cash | 105.89%1.59M | 67.56%-2.59M | -1,464.01%-27.12M | 392.98%3.71M | -39.28%4.19M | -3,930.45%-27.04M | 1.16%-7.98M | -103.43%-1.73M | -102.27%-1.27M | 213.69%6.9M |
| Effect of exchange rate changes | -118.06%-39K | -481.25%-122K | 308.14%179K | -10.78%240K | -467.86%-309K | 161.19%216K | 137.21%32K | 4.44%-86K | 6,625.00%269K | 700.00%84K |
| End cash Position | 24.04%34.45M | -39.75%32.89M | -43.07%35.6M | -43.07%35.6M | -50.19%31.65M | -50.90%27.77M | -2.86%54.6M | -2.83%62.55M | -2.83%62.55M | 653.59%63.54M |
| Free cash flow | 21.30%4.61M | 25.28%-1.22M | 156.43%15.96M | -25.70%4.29M | 37.27%9.5M | 376.07%3.8M | 77.63%-1.63M | 174.71%6.23M | 177.49%5.78M | 261.64%6.92M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data